Medtronic’s Q3 2026 revenues reach $9bn on strong PFA demand
The cardiac ablation segment within Medtronic's cardiovascular portfolio grew 80% YoY, with PFA accounting for 80% of this revenue.
18 February 2026
18 February 2026
The cardiac ablation segment within Medtronic's cardiovascular portfolio grew 80% YoY, with PFA accounting for 80% of this revenue.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.